Genomics gains momentum as EDIT, SANA, and PACB emerge as standout picks amid rapid advances in sequencing and gene editing.

The global beta thalassemia market is experiencing growth due to rising incidences and increased awareness of this genetic blood disorder. Enhanced diagnostic technologies and a growing number of ...

Corneal edema involves fluid accumulation in the cornea, leading to cloudiness and vision impairment. The market is growing due to an aging population and increasing cataract and glaucoma surgeries.

Fanconi Anemia Market Growth Driven by Genetic Research and Healthcare Investments**Fanconi Anemia (FA) is a rare genetic disorder impacting bone marrow's ability to produce blood cells, leading to ...

A Greer couple is hosting a fundraiser to support a costly gene editing procedure for their two children, who suffer from a ...

The gene editing tool known as CRISPR-Cas9 is changing what's possible for treating a wide range of diseases caused by ...

The inventor of base and prime editing shares insights on medicine's efforts to make serious genetic diseases treatable or ...

The U.S. Cellular Reprogramming Tools Market is entering a high-growth decade, projected to expand from USD 446.8 million in ...

Avalo deploys interpretable machine learning (IML) to develop more climate resilient varieties of crops such as sugarcane and ...

"Many challenges we face today are reminders of how painful and frightening it can be to confront an issue in which values ...

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of the best gene-editing stocks to buy according to hedge funds. On ...